CT-guided percutaneous microwave ablation of pulmonary malignancies: Results in 69 cases

被引:69
|
作者
Lu, Qiang [1 ]
Cao, Wei [2 ]
Huang, Lijun [1 ]
Wan, Yi [3 ,4 ]
Liu, Tonggang [5 ]
Cheng, Qingshu [1 ]
Han, Yong [1 ]
Li, Xiaofei [1 ]
机构
[1] Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian 710032, Peoples R China
[2] Fourth Mil Med Univ, Tangdu Hosp, Dept Intervent Radiol, Xian 710032, Peoples R China
[3] Fourth Mil Med Univ, Dept Hlth Stat, Xian 710032, Peoples R China
[4] Fourth Mil Med Univ, Inst Hlth Informat, Xian 710032, Peoples R China
[5] Fourth Mil Med Univ, Tangdu Hosp, Dept Resp, Xian 710032, Peoples R China
关键词
Percutaneous microwave coagulation therapy; Inoperable pulmonary malignancies; Survival rates; RADIOFREQUENCY ABLATION; LUNG MALIGNANCIES; FOLLOW-UP; THERAPY; RESECTION; CANCER; LIVER;
D O I
10.1186/1477-7819-10-80
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Microwave ablation (MWA) has attracted a worldwide attention gradually in treating inoperable pulmonary malignancies. However, in the lung tissues treated with MWA recurrence of tumor may still occur and few data in large patient groups till now were reported about the safety or effectiveness of microwave ablation in treating primary lung cancer and metastatic pulmonary malignancies. The purpose of this study is to evaluate the clinical curative effect (local control, survival data) MWA and its safety as well. Methods: From 1 January 2005 to 1 January 2008, retrospective analyses, 69 patients underwent computed tomography (CT)-guided percutaneous MWA of pulmonary malignancies. All patients were deemed medically inoperable. The correlation of tumor sizes and local progression after ablation was analyzed and the survival rates within 3 years post surgery were compared between non-small-cell lung cancer and pulmonary metastases groups also. Results: Pneumothorax was the most frequent complication and occurred in 24.64% patients after ablation. Neither needle track implantation was found nor did patient death occur in these patients within 30 days. The 1-, 2-, and 3-year overall survival rates were 66.7%, 44.9% and 24.6%, respectively. The overall survival rates for NSCLC patients in 1 year, 2 years, and 3 years were 75.0%, 54.2%, and 29.2%, respectively. The overall survival rates for pulmonary metastatic tumor patients in 1 year, 2 years, and 3 years were 47.6%, 23.8%, and 14.3%, respectively. The recurrence-free survival rates for NSCLC patients in 1 year, 2 years, and 3 years were 72.9%, 50.0%, and 27.1%, respectively. The mortality rates for pulmonary metastatic tumor patients in 1 year, 2 years, and 3 years were 47.6%, 19.0%, and 14.3%, respectively. Conclusions: Percutaneous microwave coagulation therapy was one safe and effective method and could be beneficial for the improvement of inoperable pulmonary malignancies treatment effect.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] CT-guided percutaneous microwave ablation of pulmonary malignancies: Results in 69 cases
    Qiang Lu
    Wei Cao
    Lijun Huang
    Yi Wan
    Tonggang Liu
    Qingshu Cheng
    Yong Han
    Xiaofei Li
    World Journal of Surgical Oncology, 10
  • [2] Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation - Preliminary results
    Suh, RD
    Wallace, AB
    Sheehan, RE
    Heinze, SB
    Goldin, JG
    RADIOLOGY, 2003, 229 (03) : 821 - 829
  • [3] CT-guided percutaneous microwave ablation of pulmonary malignant tumors
    Ko, Wei-Chun
    Lee, Yee-Fan
    Chen, Yi-Chang
    Chien, Ning
    Huang, Yu-Sen
    Tseng, Yao-Hui
    Lee, Jang-Ming
    Hsu, Hsao-Hsun
    Chen, Jin-Shing
    Chang, Yeun-Chung
    JOURNAL OF THORACIC DISEASE, 2016, 8 : S659 - S665
  • [4] CT-Guided Percutaneous Microwave Ablation of Adrenal Malignant Carcinoma Preliminary Results
    Li, Xin
    Fan, Weijun
    Zhang, Liang
    Zhao, Ming
    Huang, Zilin
    Li, Wang
    Gu, Yangkui
    Gao, Fei
    Huang, Jinhua
    Li, Chuanxing
    Zhang, Fujun
    Wu, Peihong
    CANCER, 2011, 117 (22) : 5182 - 5188
  • [5] CT-Guided Percutaneous Microwave Ablation of Sclerosing Hepatic Carcinoma
    Song, Hongshen
    Ding, Huaiyin
    Zhu, Chuandong
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 2020
  • [6] CT-guided Percutaneous Microwave Ablation Combined with Local Radiotherapy or Chemotherapy of Malignant Pulmonary Tumors
    Xu, Rongde
    Chen, Jingjing
    Chen, Daohua
    Zhang, Xiaobo
    Cui, Wei
    Deng, Yi
    Sun, Danxiong
    Yuan, Bing
    Li, Jing
    CURRENT RADIOPHARMACEUTICALS, 2024, 17 (02) : 184 - 199
  • [7] A prospective trial of CT-guided percutaneous microwave ablation for lung tumors
    Reisenauer, Janani S.
    Eiken, Patrick W.
    Callstrom, Matthew R.
    Johnson, Geoffrey B.
    Pierson, Karlyn
    Lechtenberg, Bettie
    Blackmon, Shanda H.
    JOURNAL OF THORACIC DISEASE, 2022, : 939 - 951
  • [8] CT-guided pulmonary radiofrequency ablation
    Haasbeek, Cornelis J. A.
    Senan, Suresh
    Smit, Egbert F.
    Lagerwaard, Frank J.
    RADIOLOGY, 2008, 246 (01) : 334 - 334
  • [9] CT-guided Percutaneous Microwave Ablation of Liver Metastases from Nasopharyngeal Carcinoma
    Li, Xin
    Fan, Wei-jun
    Zhang, Liang
    Zhang, Xiao-ping
    Jiang, Hua
    Zhang, Jian-lei
    Zhang, Hao
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2013, 24 (05) : 680 - 684
  • [10] Treatment efficacy of CT-guided percutaneous microwave ablation for primary hepatocellular carcinoma
    Yin, T.
    Li, W.
    Zhao, P.
    Wang, Y.
    Zheng, J.
    CLINICAL RADIOLOGY, 2017, 72 (02) : 136 - 140